Anebulo Pharmaceuticals (ANEB) Notes Payables (2020)
Anebulo Pharmaceuticals (ANEB) posted quarterly Notes Payables of $201286.0 for Q2 2020.
Anebulo Pharmaceuticals (ANEB) Notes Payables (2020) Analysis & Trends
Anebulo Pharmaceuticals (ANEB) has reported Notes Payables for 1 consecutive years, with $201286.0 the latest figure, recorded in Q2 2020.
- In Q2 2020, Notes Payables changed N/A year-over-year to $201286.0; the TTM figure through Jun 2020 stood at $201286.0 (changed N/A YoY), while the FY2020 annual figure was $201286.0, changed N/A from the prior year.
- Notes Payables steadied at $201286.0 in Q2 2020 per ANEB's latest filing.
- Across five years, Notes Payables topped out at $201286.0 in Q2 2020 and bottomed at $201286.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | Anebulo Pharmaceuticals | 16.43 Mn | 16.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 201,286.00 |